Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder
NCT02466386
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
113
Enrollment
INDUSTRY
Sponsor class
Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
DRUG:
SPD489
Sponsor
Shire